Elevance Health Aktie 26124340 / US0367521038
371.21
USD
-2.44
USD
-0.65%
27.12.2024
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Elevance Health Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2023 | Elevance Health Inc Registered Shs | 1.26 | 5.92 | USD |
| 2022 | Elevance Health Inc Registered Shs | 1.00 | 5.12 | USD |
| 2021 | Elevance Health Inc Registered Shs | 0.98 | 4.52 | USD |
| 2020 | Elevance Health Inc Registered Shs | 1.18 | 3.80 | USD |
| 2019 | Elevance Health Inc Registered Shs | 1.06 | 3.20 | USD |
| 2018 | Elevance Health Inc Registered Shs | 1.14 | 3.00 | USD |
| 2017 | Elevance Health Inc Registered Shs | 1.20 | 2.70 | USD |
| 2016 | Elevance Health Inc Registered Shs | 1.81 | 2.60 | USD |
| 2015 | Elevance Health Inc Registered Shs | 1.79 | 2.50 | USD |
| 2014 | Elevance Health Inc Registered Shs | 1.39 | 1.75 | USD |
Gewinn je Aktie- Elevance Health
| 25.2 23 | 24.8 22 | 24.7 21 | 18.0 20 | 18.5 19 | 14.2 18 | 14.4 17 |
Umsatz je Aktie- Elevance Health
| 722 23 | 645 22 | 562 21 | 479 20 | 400 19 | 349 18 | 336 17 |
KGV- Elevance Health
| 18.7 23 | 20.7 22 | 18.7 21 | 17.9 20 | 16.4 19 | 18.5 18 | 15.7 17 |
Elevance Health Inc Registered Shs: Die Aktie (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie berichtet | 25.22 | 24.81 | 24.73 | 17.98 | 18.47 | 14.19 | 14.35 |
| Gewinn je Aktie unverwässert | 25.38 | 25.10 | 25.04 | 18.23 | 18.81 | 14.53 | 14.70 |
| Gewinn je Aktie verwässert | 25.22 | 24.81 | 24.73 | 17.98 | 18.47 | 14.19 | 14.35 |
| Dividende pro Aktie | 5.92 | 5.12 | 4.52 | 3.80 | 3.20 | 3.00 | 2.70 |
| Gesamtdividendenausschüttung in Mio. | 1’395.00 | 1’229.00 | 1’104.00 | 954.00 | 818.00 | 776.00 | 704.90 |
Elevance Health Inc Registered Shs: Unternehmenskennzahlen (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Umsatz je Aktie | 721.74 | 644.95 | 561.75 | 479.23 | 400.36 | 348.62 | 336.22 |
| KGV (Jahresendkurs, EPS unverwässert) | 18.70 | 20.67 | 18.74 | 17.86 | 16.35 | 18.50 | 15.68 |
| KGV (Jahresendkurs, EPS verwässert) | 18.70 | 20.67 | 18.74 | 17.86 | 16.35 | 18.50 | 15.68 |
| KGV (Jahresendkurs) | 18.70 | 20.67 | 18.74 | 17.86 | 16.35 | 18.50 | 15.68 |
| Dividendenrendite Jahresende in % | 1.26 | 1.00 | 0.98 | 1.18 | 1.06 | 1.14 | 1.20 |
| Eigenkapitalquote in % | 36.18 | 35.41 | 37.07 | 37.61 | 40.54 | 39.38 | 37.09 |
| Fremdkapitalquote in % | 63.82 | 64.59 | 62.93 | 62.39 | 59.46 | 60.62 | 62.91 |
Elevance Health Inc Registered Shs: GuV (in Mio. USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 171’340.00 | 156’595.00 | 138’639.00 | 121’867.00 | 104’213.00 | 92’105.00 | 90’039.40 |
| Umsatzveränderung in % | 9.42 | 12.95 | 13.76 | 16.94 | 13.15 | 2.29 | 5.96 |
| Bruttoergebnis vom Umsatz | - | - | - | - | - | - | - |
| Bruttoergebnisveränderung in % | - | - | - | - | - | - | - |
| Operatives Ergebnis | 8’745.00 | 8’659.00 | 8’946.00 | 7’711.00 | 6’733.00 | 5’837.00 | 4’985.20 |
| Veränderung Operatives Ergebnis in % | 0.99 | -3.21 | 16.02 | 14.53 | 15.35 | 17.09 | -8.01 |
| Ergebnis vor Steuern | 7’715.00 | 7’769.00 | 7’925.00 | 6’238.00 | 5’985.00 | 5’068.00 | 3’963.80 |
| Veränderung Ergebnis vor Steuern in % | -0.70 | -1.97 | 27.04 | 4.23 | 18.09 | 27.86 | -12.99 |
| Ergebnis nach Steuer | 5’987.00 | 6’025.00 | 6’104.00 | 4’572.00 | 4’807.00 | 3’750.00 | 3’842.80 |
| Veränderung Ergebnis nach Steuer in % | -0.63 | -1.29 | 33.51 | -4.89 | 28.19 | -2.41 | 55.59 |
Elevance Health Inc Registered Shs: Bilanz (in Mio. USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gesamtverbindlichkeiten | 69’523 | 66’378 | 61’332 | 55’077 | 46’526 | 43’929 | 44’957 |
| Langzeit Gesamtverbindlichk. pro Aktie | - | - | - | - | - | - | - |
| Eigenkapital | 39’405 | 36’394 | 36’128 | 33’199 | 31’728 | 28’541 | 26’503 |
| Veränderung Eigenkapital in % | 8.26 | 0.68 | 8.62 | 4.64 | 11.17 | 7.69 | 5.59 |
| Bilanzsumme | 108’928 | 102’772 | 97’460 | 88’276 | 78’254 | 72’470 | 71’460 |
| Veränderung Bilanzsumme in % | 5.99 | 5.45 | 10.40 | 12.81 | 7.98 | 1.41 | 7.64 |
Elevance Health Inc Registered Shs: Sonstige Angaben (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | 25.38 | 25.10 | 25.04 | 18.23 | 18.81 | 14.53 | 14.70 |
| Veränderung Gewinn je Aktie (unverwässert) in % | 1.10 | 0.27 | 37.34 | -3.11 | 29.49 | -1.13 | 56.42 |
| Gewinn je Aktie (verwässert) | 25.22 | 24.81 | 24.73 | 17.98 | 18.47 | 14.19 | 14.35 |
| Veränderung Gewinn je Aktie (verwässert) in % | 1.63 | 0.33 | 37.57 | -2.64 | 30.11 | -1.09 | 55.77 |
| Anzahl Mitarbeiter | 104’900 | 102’300 | 98’200 | 83’400 | 70’600 | 63’900 | 56’000 |
| Veränderung Anzahl Mitarbeiter in % | 2.54 | 4.18 | 17.75 | 18.13 | 10.49 | 14.11 | 5.66 |
Elevance Health Inc Registered Shs Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Elevance Health Inc Registered Shs | Quartalszahlen | 22.01.2025 |
| Elevance Health Inc Registered Shs | Quartalszahlen | 16.04.2025 |
| Elevance Health Inc Registered Shs | Quartalszahlen | 16.07.2025 |
| Elevance Health Inc Registered Shs | Quartalszahlen | 15.10.2025 |
Elevance Health Inc Registered Shs vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q3 2024 Earnings Release | 17.10.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 17.07.2024 |
| Hauptversammlung | Annual General Meeting | 15.05.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 18.04.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 24.01.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 18.10.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 19.07.2023 |
| Hauptversammlung | Annual General Meeting | 10.05.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 19.04.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 25.01.2023 |
| Quartalszahlen | Q3 2022 Earnings Release | 19.10.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 20.07.2022 |
| Hauptversammlung | Annual General Meeting | 18.05.2022 |
| Quartalszahlen | Q1 2022 Earnings Release | 20.04.2022 |
| Quartalszahlen | Q4 2021 Earnings Release | 26.01.2022 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99.79 |
| The Vanguard Group, Inc. | 9.15 |
| Vanguard Group, Inc. (Subfiler) | 8.76 |
| State Street Corp. | 4.61 |
| T. Rowe Price Associates, Inc. (IM) | 4.39 |
| T Rowe Price Associates, Inc. (13F Subfiler) | 4.22 |
| Vanguard Total Stock Market ETF | 3.16 |
| BlackRock Fund Advisors | 2.73 |
| Vanguard 500 Index Fund | 2.65 |
| BlackRock Institutional Trust Co. NA | 2.27 |
| Geode Capital Management LLC | 2.09 |
| Sanders Capital LLC | 1.99 |
| Wellington Management Co. LLP (Wellington Breakout) | 1.84 |
| Capital Research & Management Co. (International Investors) | 1.66 |
| Norges Bank (13F) | 1.31 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 56’000 | 63’900 | 70’600 | 83’400 | 98’200 |
| Umsatz pro Mitarbeiter in Mio. EUR | 1.61 | 1.44 | 1.48 | 1.46 | 1.41 |
Bilanz (in Mio. USD) - Aktiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 36’263 | 34’321 | 39’033 | 45’751 | 51’122 |
| Summe Anlagevermögen | 35’197 | 38’149 | 39’221 | 42’525 | 46’338 |
| Summe Aktiva | 71’460 | 72’470 | 78’254 | 88’276 | 97’460 |
Bilanz (in Mio. USD) - Passiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 44’957 | 43’929 | 46’526 | 55’077 | 61’332 |
| Summe Eigenkapital | 26’503 | 28’541 | 31’728 | 33’199 | 36’128 |
| Summe Passiva | 71’460 | 72’470 | 78’254 | 88’276 | 97’460 |
Adresse
| 220 Virginia Avenue, 46204 Indianapolis | |
| Telefon | +1 (800) 331-1476 |
| URL | http://www.elevancehealth.com |
Management
|
Antonio Fabio Neri
Independent Director |
|
Bahija Jallal
Independent Director |
|
Blair W. Todt
Executive VP, Chief Legal & Administrative Officer |
|
Bryony Winn
President-Health Solutions |
|
Chris Rigg
Senior VP & CFO-Commercial & Specialty Business |
|
Deanna Dawnette Strable-Soethout
Independent Director |
|
Dustin Wilcox
Chief Information Security Officer |
|
Elizabeth E. Tallett
Independent Chairman |
|
Felicia Farr Norwood
EVP & President-Government Health Benfits |
|
Gail Koziara Boudreaux
President, Chief Executive Officer & Director |
|
Hakon Mattson
Chief Sustainability Officer |
|
Jill A. Becher
Vice President-Planning & Execution |
|
Kathleen S. Kiefer
Secretary & Chief Governance Officer |
|
Kyle Weber
Chief Strategy Officer |
|
Lewis Hay
Independent Director |
|
Marcus D. Wilson
Chief Analytics Officer |
|
Mark B. Kaye
Chief Financial Officer & Executive Vice President |
|
Morgan Kendrick
EVP & President-Commercial & Specialty Business |
|
Nathan Rich
Vice President-Investor Relations |
|
Peter David Haytaian
Executive VP, President-Carelon & CarelonRX |
|
R. Kerry Clark
Independent Director |
|
Rachel Stuve
Sr. Director Data Science & AI |
|
Ramiro G. Peru
Independent Director |
|
Ratnakar Lavu
Chief Digital Information Officer & Executive VP |
|
Robert L. Dixon
Independent Director |
|
Ronald William Penczek
Chief Accounting Officer & Controller |
|
Ryan M. Schneider
Independent Director |
|
Scott Towers
President-Dental Business |
|
Shantanu Agrawal
Chief Health Officer |
|
Susan D. DeVore
Independent Director |